GlassScriptPhysician profile
Harold L Bolnick
NPI 1346205549
$1,056.59
in general payments reported to CMS, 2019-2025
19 companies · $82.31 in 2025
The $82.31 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $33.42 · 2021: $15.57 · 2022: $129 · 2023: $246 · 2024: $362 · 2025: $82.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $190.76 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Flx, General - Therapies |
| Covidien LP | $177.30 | 2019 | |
| Collegium Pharmaceutical, INC. | $159.13 | 2023-2024 | Belbuca, Nucynta |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2024 | Exparel |
| Abbvie INC. | $74.98 | 2024 | |
| Scilex Pharmaceuticals INC. | $55.79 | 2021-2024 | |
| Amgen INC. | $33.42 | 2020 | |
| Lilly USA, LLC | $27.72 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.18 | 2022 | |
| Lundbeck LLC | $24.70 | 2023 | Vyepti |
| Indivior INC. | $23.44 | 2024 | Sublocade |
| Bioventus LLC | $23.42 | 2023 | Durolane |
| Teva Pharmaceuticals USA, INC. | $21.03 | 2022 | |
| Innovation Technologies INC | $19.37 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.50 | 2023 | Seglentis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $15.33 | 2023 | Lyvispah |
| Forte Bio-Pharma LLC | $14.74 | 2024 | Prolate, Nalocet |
| Biohaven Pharmaceutical Holding Company LTD. | $14.72 | 2022 | |
| Curonix LLC | $14.06 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Bolnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.